AVITA Medical, Inc. (RCEL) Net Equity Issued and Repurchased (2020 - 2021)

AVITA Medical (RCEL) has reported Net Equity Issued and Repurchased for 2 consecutive years, with $69.1 million the latest figure, recorded in Q3 2021.

• For the quarter ending Q3 2021, Net Equity Issued and Repurchased changed N/A year-over-year to $69.1 million; the trailing twelve-month figure through Dec 2025 stood at $138.2 million (changed N/A YoY), and the FY2025 full-year result was $14.8 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased held at $69.1 million in Q3 2021 per RCEL's latest filing, from $69.1 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $69.1 million in Q1 2021 and bottomed at $1000.0 in Q1 2020.